Psychopharmacology Bulletin, V47, N3: Links to In-Depth Articles ORIGINAL PRESENTATIONS Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder. By Brianne Brown, Larry Alphs, Ibrahim Turkoz, Yong Yue Correlation of Caregiver Burden and Baseline Characteristics of Caregivers and Patients [...]
This work was sponsored by a Young Investigator Grant from the American Foundation for Suicide Prevention (AFSP) BACKGROUND Suicide is preventable, yet still remains a worldwide cause of death in part due to a lack of available medical interventions that can work during a suicidal crisis. Most potentially helpful medications [...]
The US Food and Drug Administration (FDA) has approved a new formulation of methylphenidate for children with attention-deficit/hyperactivity disorder (ADHD). Cotempla XR-ODT (Neos Therapeutics Inc) is the first and only methylphenidate extended-release orally disintegrating tablet for the treatment of ADHD in patients aged 6 to 17 years, the company said [...]
By Megan Brooks BOSTON — Sleep-disordered breathing (SDB) may play a role in persistent depressive symptoms and poor response to standard pharmacologic treatments in adolescents, new research suggests. Screening adolescents with treatment-resistant depression (TRD) for SBD "may be clinically valuable, since SDB is readily treatable," said Teena Chase, MD, PhD, Department [...]
By Nassir Ghaem Wide-Ranging Benefits At the recent American Psychiatric Association annual meeting in San Diego, an update symposium was presented on the topic of "Lithium: Key Issues for Practice."[1] In a session chaired by Dr David Osser, associate professor of psychiatry at Harvard Medical School, presenters reviewed various aspects of [...]
Original Investigation By Jari Tiihonen, MD, Ellenor Mittendorfer-Rutz, Maila Majak; et al Key Points Question Are there any clinically meaningful differences between specific antipsychotic medications or routes of administration regarding the risk of psychiatric rehospitalization or other treatment failure? Findings This database study of a nationwide cohort of patients using within-individual analysis to eliminate [...]
MIAMI – Medications in development for the treatment of attention-deficit/hyperactivity disorder (ADHD) target specific behaviors, such as impulsive aggression, and genes that involve the glutamatergic network, new research shows. In the first of two studies presented here at the American Society of Clinical Pharmacology (ASCP), researchers reported on improvements in [...]
New Insight Into Off-Label Ketamine Use for Depression By Nancy A. Melville MIAMI – As the off-label use of ketamine for the treatment of severe depression continues to soar, two new studies provide insight into the way clinicians are using it in the field, away from the research setting. In [...]
Anne Katrine Pagsberg , Pia Jeppesen, Dea Gowers Klauber, Karsten Gjessing Jensen, Ditte Rudå, Marie Stentebjerg-Olesen, Peter Jantzen, Simone Rasmussen, Eva Ann-Sofie Saldeen, Britt Glenn Lauritsen, Niels Bilenberg, Anne Dorte Stenstrøm, Louise Nyvang , Sarah Madsen, Thomas M Werge, Theis Lange ,Christian Gluud, Maria Skoog, Peter Winkel, Jens Richardt, M Jepsen, Birgitte Fagerlund, Christoph U Correll, Anders Fink-Jensen Summary Background Head-to-head trials to guide antipsychotic treatment choices for paediatric psychosis are urgently needed because [...]
From Depths of Addiction to Triumph of Recovery: ABC Journalist Shares Story of Strength and Inspiration Elizabeth Vargas , who delivered the 2017 William C. Menninger Memorial Award Lecture Monday evening, has traveled the world covering breaking news stories, reporting on in-depth investigations, and conducting interviews with high-profile newsmakers. She’s [...]